Exhibitor Details

Back

INTERMED LABORATORIES PRIVATE LIMITED

A3 TODI INDUSTRIAL ESTATE, SUNMILL COMPOUND, LOWER PAREL, MUMBAI 400013. INDIA.
WWW.INTERMEDINDIA.COM

Product Categories

Formulations
ACECLOFENAC (100 MG) + PARACETAMOL (500 MG),ALBENDAZOLE (400 MG),ALENDRONATE (75 MG),AMITRIPTYLINE (25 MG),AMLODIPINE (10 MG),AMLODIPINE (5 MG),ARTEMETHER (20 MG) + AZITHROMYCIN (120 MG),ASPIRIN (400 MG) + PARACETAMOL (100 MG) + CAFFEINE (30 MG),AZITHROMYCIN (500 MG),Captopril-25mg,DICLOFENAC (50 MG) + PARACETAMOL (500 MG),FLUCONAZOLE (100 MG),FLUCONAZOLE (150 MG),IBUPROFEN (200 MG) + PARACETAMOL (325 MG) + CAFFEINE (30 MG),IBUPROFEN (400 MG),Metformin(850mg),MULTIVITAMINS (NA) + MULTIMINERALS (NA),PARACETAMOL (500 MG) + CAFFEINE (30 MG),PHENYTOIN (100 MG),PROMETHAZINE (25 MG),PROPRANOLOL (40 MG),SILDENAFIL (100 MG),SULFAMETHOXAZOLE (200 MG) + TRIMETHOPRIM (40 MG),SULFAMETHOXAZOLE (400 MG) + TRIMETHOPRIM (80 MG),TELMISARTAN (40 MG),TERBINAFINE (250 MG),VITAMIN B COMPLEX (NA)
Hydrogel topical pain relief patches: lidocaine 5%, menthol 5%, lidocaine 4%, lidocaine 4%+ menthol1 %, menthol 1%+methyl salicylate 1.5%,capsicin 0.025% + menthol 1% , ibuprofen , diclofeanc 1% patch

Company Profile

* ESTABLISHED IN 1981, INTERMED LABORATORIES IS A GLOBAL PHARMACEUTICAL MANUFACTURING AND MARKETING COMPANY. * SUPPLYING QUALITY MEDICINES TO OVER 35 COUNTRIES ACROSS THE US, AFRICA, LATIN AMERICA, SOUTH-EAST ASIA, CENTRAL ASIA, AUSTRALIA, AND OTHER MARKETS. * STRONG PRESENCE IN BOTH GOVERNMENT AND PRIVATE PHARMACEUTICAL SECTORS. * THREE STATE-OF-THE-ART MANUFACTURING FACILITIES LOCATED IN CHENNAI, INDIA. * REGULATORY APPROVALS INCLUDE USFDA, TGA AUSTRALIA, UAE MOHAP, WHO-GMP, TMDA TANZANIA, AND OTHER INTERNATIONAL AGENCIES. * WIDE THERAPEUTIC PORTFOLIO COVERING ANTIBIOTICS, ANTI-MALARIALS, ANTI-TB, ARVS, CARDIOLOGY, DIABETES, ONCOLOGY, RESPIRATORY, DERMATOLOGY, AND MORE. * A ONE-STOP PHARMACEUTICAL PARTNER OFFERING COMPREHENSIVE MANUFACTURING CAPABILITIES.